RxDoctor Payments Data

Dozier Hood, MD

Otolaryngology · Fayetteville, GANPI 1023015195

Payments from drug & device makers

What this record shows

This record is dominated by other: $343,552 of the $346,535 with a category attached, or 99.1%. Zimmer Biomet accounts for 99.1% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2023 at $343,708 and has fallen 99.9% since, to $404 in 2025. Among otolaryngology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$346,535in general payments, 2019–2025

Across 88 payments — averaging $3937.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$344K
  • Stryker$1K
  • Sanofi$429
  • Regeneron Healthcare Solutions, Inc.$187
  • Aerin Medical Inc.$183
  • Optinose US, Inc.$177
  • plus $520 from 18 others
$368,222in ownership & investment interests, 2019–2025

Across 3 payments — averaging $122,741 each. An ownership or investment interest held by the physician or an immediate family member.

  • Zimmer Biomet$368K

What the payments were for

  • Travel & lodging$8540%
  • Food & beverage$2,1291%
  • Other$343,55299%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$346,535 in reported general payments places this provider in the 95th percentile of 308 otolaryngology providers in Georgia.

See all otolaryngology providers in Georgia

Medicare billing

Part B allowed, 2024
$255,816
Medicare patients
1,016
Services billed
4,513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CefuroximeCefuroxime Axetil154$2,927
Ipratropium Bromide75$2,350
Ofloxacin43$1,658
Azelastine Hcl66$1,596
Fluticasone Propionate70$883
Clobetasol Propionate46$765
Omeprazole89$537
Doxycycline Hyclate15$470
Nystatin36$331
Mupirocin48$305
Methylprednisolone38$210
Levocetirizine Dihydrochloride26$201
Zolpidem Tartrate17$195
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$167
Azithromycin39$160

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Fayetteville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →